BioCentury | Jan 15, 2007
Company News

Abbott, Boston Scientific sales and marketing update

...U.S. next year. ABT obtained the stent when it acquired the vascular business of BSX's Guidant Corp....
BioCentury | Oct 23, 2006
Clinical News

Promus regulatory update

...distributes it as Xience V . In May, ABT acquired the vascular business of BSX's Guidant Corp....
BioCentury | Oct 16, 2006
Company News

Endocyte management update

...Drug delivery Hired: Michael Sherman as CFO, formerly VP of finance and strategic planning at Guidant Corp. WIR...
BioCentury | Oct 9, 2006
Finance

Ebb & Flow

...Nic Chronos and Michael Gertner joined as adjunct partners. Neels was COO of device company Guidant...
BioCentury | Sep 18, 2006
Company News

Endocyte board of directors update

...Ind. Business: Cancer, Drug delivery Appointed: Keith Brauer, former VP of finance and CFO at Guidant Corp. WIR...
BioCentury | Sep 18, 2006
Company News

Bristol-Myers management update

...as CEO and Richard Willard as SVP and general counsel; James Cornelius, chairman emeritus of Guidant Corp....
BioCentury | Sep 13, 2006
Top Story

Dolan leaves Bristol-Myers

...the board to terminate Dolan's employment. James Cornelius, a BMY director and chairman emeritus of Guidant...
BioCentury | May 1, 2006
Company News

Abbott, Boston Scientific deal

...ABT acquired the vascular business of BSX's Guidant Corp. unit for $4.1 billion in cash. ABT also...
...the company. BSX is eligible for a $250 million milestone payment upon FDA approval of Guidant's...
...ABT's deal with BSX was in conjunction with BSX completing its previously announced acquisition of Guidant...
BioCentury | Apr 19, 2006
Financial News

JNJ beats Street EPS

...$622 million, or $0.12 per share, associated with the termination of an agreement to acquire Guidant...
BioCentury | Mar 13, 2006
Clinical News

Everolimus stent: Pilot trial started

...An initial assessment will be performed at 6 months, and a follow-up at 5 years. Guidant Corp....
Items per page:
1 - 10 of 98
BioCentury | Jan 15, 2007
Company News

Abbott, Boston Scientific sales and marketing update

...U.S. next year. ABT obtained the stent when it acquired the vascular business of BSX's Guidant Corp....
BioCentury | Oct 23, 2006
Clinical News

Promus regulatory update

...distributes it as Xience V . In May, ABT acquired the vascular business of BSX's Guidant Corp....
BioCentury | Oct 16, 2006
Company News

Endocyte management update

...Drug delivery Hired: Michael Sherman as CFO, formerly VP of finance and strategic planning at Guidant Corp. WIR...
BioCentury | Oct 9, 2006
Finance

Ebb & Flow

...Nic Chronos and Michael Gertner joined as adjunct partners. Neels was COO of device company Guidant...
BioCentury | Sep 18, 2006
Company News

Endocyte board of directors update

...Ind. Business: Cancer, Drug delivery Appointed: Keith Brauer, former VP of finance and CFO at Guidant Corp. WIR...
BioCentury | Sep 18, 2006
Company News

Bristol-Myers management update

...as CEO and Richard Willard as SVP and general counsel; James Cornelius, chairman emeritus of Guidant Corp....
BioCentury | Sep 13, 2006
Top Story

Dolan leaves Bristol-Myers

...the board to terminate Dolan's employment. James Cornelius, a BMY director and chairman emeritus of Guidant...
BioCentury | May 1, 2006
Company News

Abbott, Boston Scientific deal

...ABT acquired the vascular business of BSX's Guidant Corp. unit for $4.1 billion in cash. ABT also...
...the company. BSX is eligible for a $250 million milestone payment upon FDA approval of Guidant's...
...ABT's deal with BSX was in conjunction with BSX completing its previously announced acquisition of Guidant...
BioCentury | Apr 19, 2006
Financial News

JNJ beats Street EPS

...$622 million, or $0.12 per share, associated with the termination of an agreement to acquire Guidant...
BioCentury | Mar 13, 2006
Clinical News

Everolimus stent: Pilot trial started

...An initial assessment will be performed at 6 months, and a follow-up at 5 years. Guidant Corp....
Items per page:
1 - 10 of 98